TANDEM DIABETES CARE, INC. — Revenue by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/685f784c-b65b-4361-8944-ebebad3596f8/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.0B | 2025-01-01 – 2025-12-31 | evidence 0001438133-26-000010 |
| FY 2024 | $940.2M | 2024-01-01 – 2024-12-31 | evidence 0001438133-25-000036 |
| FY 2023 | $747.7M | 2023-01-01 – 2023-12-31 | evidence 0001438133-24-000028 |
| FY 2022 | $801.2M | 2022-01-01 – 2022-12-31 | evidence 0001438133-23-000031 |
| FY 2021 | $702.8M | 2021-01-01 – 2021-12-31 | evidence 0001438133-22-000021 |
| FY 2020 | $498.8M | 2020-01-01 – 2020-12-31 | evidence 0001438133-21-000015 |
| FY 2019 | $362.3M | 2019-01-01 – 2019-12-31 | evidence 0001438133-20-000014 |
| FY 2018 | $183.9M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004469 |
| FY 2017 | $107.6M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-004469 |
| FY 2016 | $84.2M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-004469 |
| FY 2015 | $72.8M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013192 |
| FY 2014 | $49.7M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-000886 |
| FY 2013 | $29.0M | 2013-01-01 – 2013-12-31 | evidence 0001564590-15-000886 |
| FY 2012 | $2.5M | 2012-01-01 – 2012-12-31 | evidence 0001564590-15-000886 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TANDEM DIABETES CARE, INC. — all facts · Net Income · Operating Income